CDC and Kid Risk modeled polio's endgame, reshaping global vaccine policy

By the early 2000s polio eradication had stalled into its most expensive and dangerous phase. The Global Polio Eradication Initiative (GPEI), whose four spearheading partners include the U.S. Centers for Disease Control and Prevention, faced choices with no obvious answers: whether eradication was still worth pursuing instead of control, how aggressively to answer each outbreak, and what to do with the oral vaccine itself, whose weakened live virus can circulate and paralyze once wild polio is gone.

In 2001 the CDC launched a collaboration with Kid Risk, Inc. to build integrated analytical models of these choices. The work combined operations research tools — simulation, decision and risk analysis, system dynamics, and optimization — with field evidence, quantifying the global risks, benefits and costs of every policy option in one consistent framework.

The models changed policy in three documented ways. They showed that faster outbreak response shrinks both response time and outbreak size, helping motivate a global resolution institutionalizing rapid response. They underpinned a 192-country resolution to coordinate global cessation of one of the two oral polio vaccines after wild poliovirus eradication — the logic behind the synchronized global switch from trivalent to bivalent oral vaccine in the GPEI's endgame plan. And they made the economic case: an estimated $40–50 billion in net benefits for countries supported by the GPEI.

The quantified case moved money. Recognition of polio eradication as a program needing stable financing helped support a 2013 fundraising effort that raised over $4 billion from donors. On March 31, 2014, the CDC and Kid Risk collaboration won the Franz Edelman Award, INFORMS's top practice prize. WHO's Bruce Aylward, who led the polio program, said the work had been 'fundamental to so much of what's happened in the polio eradication program' and had supported 'many of our decisions over the last decade.'

Model the whole disease system before picking policies

Eradication is a one-shot game: stopping vaccination too early risks re-importation and outbreaks, so the tail risk had to be priced before any country would commit.

Synchronized global action needs a shared number; 192 countries would not coordinate a vaccine switch without a common quantified case for why it was safe.

Donors fund arithmetic — the estimated $40–50 billion in net benefits gave fundraisers a concrete return to campaign on, helping unlock over $4 billion in 2013.

Modeling showed outbreak response speed compounds: faster response means smaller outbreaks, which converted an operational instinct into global policy.

The collaboration paired a spearheading partner (CDC) with an independent modeling group, so the analysis could challenge program orthodoxy while staying inside the trust circle.

For one-shot global decisions, the model is the negotiation room. Quantifying each party's downside is what lets sovereign states move together on a schedule no single country would risk alone.

The team's paper appeared in the INFORMS Edelman special issue, and the collaboration forecast its own future: expanded probabilistic and dynamic modeling for other vaccine-preventable diseases such as measles and rubella. The coordinated trivalent-to-bivalent vaccine switch the models underpinned became a cornerstone of the GPEI's endgame strategic plan, and the prize committee credited the collaboration with reaffirming eradication over control as the 'best buy' against paralysis.